OraQuick® HCV
Hepatitis C
CommercialFDA Approved; Marketed
Key Facts
About OraSure
OraSure Technologies (OSUR) is a mission-driven diagnostics company focused on decentralizing healthcare through a portfolio of non-invasive testing and sample collection platforms. Its strategy has been built on internal innovation and strategic acquisitions, including DNA Genotek (sample management), BioMedomics (point-of-care rapid tests), and Sherlock Biosciences (next-gen molecular platforms). This has created a comprehensive ecosystem from sample to result, targeting infectious diseases, genetic conditions, and research applications. The company aims to improve healthcare access, quality, and value by empowering individuals and providers with actionable diagnostic insights.
View full company profileTherapeutic Areas
Other Hepatitis C Drugs
| Drug | Company | Phase |
|---|---|---|
| MDL-001 | Model Medicines | Preclinical |
| ALF Platform | Senzo | Pre-clinical |
| Broad-Spectrum Candidates | NanoViricides | Preclinical |